Engineers Gate Manager’s Intellia Therapeutics NTLA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.54M	Buy	120,356 +37,305	+45%	+$475K	0.02%	840
2025 Q4	$747K	Sell	83,051 -15,238	-16%	-$210K	0.01%	1179
2025 Q3	$1.7M	Sell	98,289 -34,725	-26%	-$428K	0.02%	850
2025 Q2	$1.25M	Buy	133,014 +8,450	+7%	+$69.4K	0.02%	998
2025 Q1	$886K	Sell	124,564 -23,603	-16%	-$238K	0.01%	1132
2024 Q4	$1.73M	Buy	148,167 +96,410	+186%	+$1.5M	0.03%	693
2024 Q3	$1.06M	Sell	51,757 -9,771	-16%	-$225K	0.02%	952
2024 Q2	$1.38M	Buy	+61,528	New	+$1.46M	0.03%	737
2023 Q4	–	Sell	-23,349	Closed	-$738K	–	2155
2023 Q3	$738K	Buy	23,349 +16,143	+224%	+$626K	0.03%	882
2023 Q2	$294K	Sell	7,206 -37,881	-84%	-$1.54M	0.01%	1312
2023 Q1	$1.68M	Buy	45,087 +6,520	+17%	+$256K	0.07%	371
2022 Q4	$1.35M	Buy	38,567 +10,109	+36%	+$481K	0.08%	329
2022 Q3	$1.59M	Buy	+28,458	New	+$1.77M	0.1%	252
2021 Q1	–	Sell	-15,150	Closed	-$824K	–	2033
2020 Q4	$824K	Sell	15,150 -30,288	-67%	-$1.1M	0.04%	683
2020 Q3	$903K	Buy	+45,438	New	+$947K	0.04%	671
2020 Q2	–	Sell	-24,539	Closed	-$300K	–	1896
2020 Q1	$300K	Buy	+24,539	New	+$331K	0.02%	1040